Paper Title

An overview on ocular drug delivery system

Article Identifiers

Registration ID: IJNRD_186359

Published ID: IJNRD2309343

DOI: Click Here to Get

Authors

Aminu Musa Wada , Shehu Yusuf

Keywords

Key words: ocular drug delivery, nanoparticles, nanotechnology, bioavailability

Abstract

ABSTRACT Ocular medication delivery is the main issue facing pharmacologists and formulation scientists today. The easiest and most widely used kind of treatment is a topical eye drop. Route of drug administration, particularly when treating disorders of the anterior region. Various precorneal, dynamic, and static ocular barriers prevent medication delivery to the targeted ocular tissues. Additionally, target tissues do not retain therapeutic medication levels for an extended period of time. The ocular preparations consist of sterile, buffered, isotonic solutions. They are employed for quick action. They are unable to hold on for an extended period. The fundamental problem with traditional ocular dose forms is that they cannot keep a therapeutic level. Ophthalmic preparations must be devoid of irritants and their physiological properties must not interfere with the eye's normal functioning or cause blurred vision of any kind. The development of innovative, secure, and patient-compliant medication formulations and drug delivery devices/techniques, which may overcome these obstacles and sustain drug levels in tissues, has increased over the past two decades in the field of ocular drug delivery research. Among the various nanoparticles currently available, lipid-based nanosystems have demonstrated increased efficiency and feasibility in topical formulations, making them an important target for ongoing and thorough research in both preclinical and clinical practice. There are numerous new drug delivery systems available for use in the eye. The current review aims to summarize the existing traditional formulations for ocular distribution and their developments, followed by the most recent innovations in formulations based on nanotechnology. Problems associated with traditional ophthalmic dosage forms may be alleviated by the new drug delivery system. Also highlighted are recent advancements in various ocular drug delivery techniques using in situ gels, implants, contact lenses, and micro needles.

How To Cite (APA)

Aminu Musa Wada & Shehu Yusuf (September-2023). An overview on ocular drug delivery system . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(9), d301-d319. https://ijnrd.org/papers/IJNRD2309343.pdf

Issue

Volume 8 Issue 9, September-2023

Pages : d301-d319

Other Publication Details

Paper Reg. ID: IJNRD_186359

Published Paper Id: IJNRD2309343

Downloads: 000121976

Research Area: Pharmacy

Country: Achrol , Rajasthan , India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2309343.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2309343

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details